Table 2.
Expression of inflammatory factors in the CSF and serum of anti-NMDAR encephalitis patients at the acute stage and 3-month follow up.
Acute stage | Follow up | p value | |
---|---|---|---|
TNF-α (pg/ml) | 7.7±5.0 | 4.4±2.9 | 0.000 |
IL-10 (pg/ml) | 6.9±3.4 | 3.5±1.7 | 0.000 |
IL-6 (pg/ml) | 10.5±5.1 | 6.0±1.6 | 0.000 |
Serum MMP2 (ng/ml) | 241.3±90.8 | 232.6±84.7 | 0.621 |
CSF MMP2 (ng/ml) | 36.6±15.0 | 31.9±13.1 | 0.170 |
Serum sCD146 (ng/ml) | 501.8±124.5 | 488.0±102.2 | 0.396 |
CSF sCD146 (ng/ml) | 54.0±32.2 | 29.9±8.5 | 0.001 |
mRS | 3.9±0.8 | 1.8±1.1 | 0.000 |